Clinical Trials in Changzhi, China
10 recruiting
Showing 1–20 of 34 trials
Recruiting
Phase 1Phase 2
TCR Reserved and Power3 (SPPL3) Gene Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B-ALL
Acute Lymphocytic Leukemia
Chinese PLA General Hospital30 enrolled6 locationsNCT06481735
Recruiting
China Diabetes Type 1 Study (CD1S) by China Alliance for Type 1 Diabetes
DiabetesType1diabetes
Second Xiangya Hospital of Central South University20,000 enrolled11 locationsNCT05498974
Recruiting
Phase 2
A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma
Gastroesophageal Adenocarcinoma
AstraZeneca100 enrolled70 locationsNCT07069712
Recruiting
Phase 3
A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Gastroesophageal Junction AdenocarcinomaMetastatic Gastric Adenocarcinoma
BeOne Medicines351 enrolled85 locationsNCT07043400
Recruiting
Phase 1
A First-in-Human (FIH) Study of BG-C137, an Anti-Fibroblast Growth Factor Receptor 2b (FGFR2b) Antibody Drug Conjugate, in Participants With Advanced Solid Tumors
Advanced Solid Tumor
BeOne Medicines168 enrolled52 locationsNCT06625593
Recruiting
Not Applicable
TrIal of Early Minimally Invasive Catheter Evacuation With Thrombolysis in IntraCerebral Hemorrhage
Intracerebral Hemorrhage
Xuanwu Hospital, Beijing750 enrolled50 locationsNCT07187687
Recruiting
Phase 3
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
COPD, Chronic Obstructive Pulmonary Disease
AstraZeneca5,000 enrolled917 locationsNCT06283966
Recruiting
Phase 3
A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer
Gastric CancerGastroesophageal-junction CancerHER2-positive Gastric Cancer+1 more
Shanghai Henlius Biotech550 enrolled208 locationsNCT06532006
Recruiting
Not Applicable
Neuroendoscopy-assisted Drainage Versus Burr Hole Drainage for Chronic Subdural Hematoma
Chronic Subdural Hematoma
Beijing Tiantan Hospital770 enrolled24 locationsNCT07144423
Recruiting
Phase 2
PCV24 Clinical Trial in Infants and Young Children Aged 2 Months (Minimum 6 Weeks) to 71 Months
Pneumococcal Infectious Disease
Shanghai Reinovax Biologics Co.,LTD480 enrolled7 locationsNCT07333352
Recruiting
Phase 1Phase 2
A Study of CM336 in Patients With Relapsed or Refractory Autoimmune Cytopenia
Autoimmune Hemolytic AnemiaEvans SyndromeAutoimmune Cytopenia+1 more
Keymed Biosciences Co.Ltd158 enrolled3 locationsNCT07175493
Recruiting
Phase 1Phase 2
A Clinical Trial of TQ05105 Tablets Combined With TQB3617 Capsules in the Treatment of Myelofibrosis (MF)
Myelofibrosis
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.92 enrolled22 locationsNCT06122831
Recruiting
Phase 2
A Clinical Study of SPH5030 Tablets in the Treatment of Her2-positive/Mutated Biliary Tract OR Colorectal Cancer Patients.
Biliary Tract or Colorectal Cancer With Her2-positive/Mutated
Shanghai Pharmaceuticals Holding Co., Ltd60 enrolled30 locationsNCT06434597
Recruiting
The Construction of a Predictive Model for Gastric Cancer Immunotherapy Response Based on Tumor-Infiltrating Lymphocytes (TILs) and Histone H3K4me3 in the Tumor Microenvironment
Gastric CancerImmunotherapy
Changzhi People's Hospital Affiliated to Changzhi Medical College170 enrolled1 locationNCT07069842
Recruiting
Real-world Effectiveness and Safety of Trastuzumab Deruxtecan in Patients With Locally Advanced or Metastatic HER2-positive Gastric or Gastroesophageal Junction Adenocarcinoma in China
HER2-positive Gastric CancerHER2-positive Gastroesophageal Junction
Daiichi Sankyo260 enrolled36 locationsNCT06846996
Recruiting
Not Applicable
Mobile Applet for Weight Management in Obese Heart Failure Patients
Heart FailureWeight LossOverweight and Obesity+1 more
Heart Health Research Center830 enrolled26 locationsNCT06455878
Recruiting
Not Applicable
OGT-assisted Overlap Esophagojejunostomy Versus Traditional Overlap Method
Gastric Cancer
Nanfang Hospital, Southern Medical University344 enrolled12 locationsNCT05450835
Recruiting
Phase 3
A Study of TQB3473 Tablets Compared to Placebo in the Treatment of Adult Primary Immune Thrombocytopenia
Primary immune thrombocytopenia
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.199 enrolled53 locationsNCT06900920
Recruiting
Phase 3
Evaluation of Safety and Efficacy of Nalbuphine Versus Morphine for Postoperative Analgesia
postoperative analgesia
Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd288 enrolled24 locationsNCT06949852
Recruiting
Phase 4
SHengXIaN-QuYu DEcoction in Heart Failure With Reduced and Mildly Reduced Ejection Fraction
Heart Failure
China-Japan Friendship Hospital336 enrolled26 locationsNCT05583773